Incyte to Present at Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Incyte (INCY) PT Raised to $67 at RBC Capital
August 15, 2024 6:14 AM EDTRBC Capital analyst Brian Abrahams raised the price target on Incyte (NASDAQ: INCY) to $67.00 (from $66.00) while maintaining a Sector Perform rating.
The analyst comments "Although axatilimabs approval came earlier than expected, we believe it was largely already baked into valuation, launch is delayed... More



